Transarterial embolization with hepatectomy for ruptured hepatocellular carcinoma: a meta-analysis

To compare the clinical effectiveness between transarterial embolization (TAE) with staged hepatectomy (SH) and emergency hepatectomy (EH) for ruptured hepatocellular carcinoma (HCC). Pubmed, Embase, and Cochrane Library databases were screened for eligible publications from the inception of the dat...

Full description

Saved in:
Bibliographic Details
Published in:Minimally invasive therapy and allied technologies 2022-06, Vol.31 (5), p.676-683
Main Authors: Zhang, Feng-Qin, Li, Lin, Huang, Ping-Chao, Fu, Yu-Fei, Xu, Qing-Song
Format: Article
Language:English
Subjects:
Hepatectomy
hepatocellular carcinoma
rupture
transarterial embolization
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c366t-f83db7b58ff493272f91d1c2b5477f0f52b6f1a037fb7f5002ade95b16077a9d3
cites cdi_FETCH-LOGICAL-c366t-f83db7b58ff493272f91d1c2b5477f0f52b6f1a037fb7f5002ade95b16077a9d3
container_end_page 683
container_issue 5
container_start_page 676
container_title Minimally invasive therapy and allied technologies
container_volume 31
creator Zhang, Feng-Qin
Li, Lin
Huang, Ping-Chao
Fu, Yu-Fei
Xu, Qing-Song
description To compare the clinical effectiveness between transarterial embolization (TAE) with staged hepatectomy (SH) and emergency hepatectomy (EH) for ruptured hepatocellular carcinoma (HCC). Pubmed, Embase, and Cochrane Library databases were screened for eligible publications from the inception of the databases till February 2021. This meta-analysis included seven studies comprising 162 patients who underwent TAE with SH and 266 patients who underwent EH. The pooled intraoperative blood loss was less in the TAE with SH cohort, as compared to the EH cohort without significant difference (p = .20). The pooled blood transfer rate (p
doi_str_mv 10.1080/13645706.2021.1986724
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmed_primary_34634985</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2581289491</sourcerecordid><originalsourceid>FETCH-LOGICAL-c366t-f83db7b58ff493272f91d1c2b5477f0f52b6f1a037fb7f5002ade95b16077a9d3</originalsourceid><addsrcrecordid>eNp9kEtPwzAMgCME4jH4CaAeuXTk0TQNJxDiJSFxGefIaRMRlDYjSYXGr6djG0dOjuzPsf0hdE7wnOAGXxFWV1zgek4xJXMim1rQag8dT3leUsnI_u-7KtfQETpJ6QNPJGfNITpiVc0q2fBjpBcRhgQxm-jAF6bXwbtvyC4MxZfL78W7WUI2bQ79qrAhFnFc5jGablMIrfF-9BCLFmLrhtDDdQFFbzKUMIBfJZdO0YEFn8zZNs7Q28P94u6pfHl9fL67fSlbVte5tA3rtNC8sbaSjApqJelISzWvhLDYcqprSwAzYbWwfDoGOiO5JjUWAmTHZuhy8-8yhs_RpKx6l9b7wWDCmBTlDaGNrCSZUL5B2xhSisaqZXQ9xJUiWK31qp1etdartnqnvovtiFH3pvvr2vmcgJsN4IZJVg9fIfpOZVj5EO1kunVJsf9n_ABAroub</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2581289491</pqid></control><display><type>article</type><title>Transarterial embolization with hepatectomy for ruptured hepatocellular carcinoma: a meta-analysis</title><source>Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list)</source><creator>Zhang, Feng-Qin ; Li, Lin ; Huang, Ping-Chao ; Fu, Yu-Fei ; Xu, Qing-Song</creator><creatorcontrib>Zhang, Feng-Qin ; Li, Lin ; Huang, Ping-Chao ; Fu, Yu-Fei ; Xu, Qing-Song</creatorcontrib><description>To compare the clinical effectiveness between transarterial embolization (TAE) with staged hepatectomy (SH) and emergency hepatectomy (EH) for ruptured hepatocellular carcinoma (HCC). Pubmed, Embase, and Cochrane Library databases were screened for eligible publications from the inception of the databases till February 2021. This meta-analysis included seven studies comprising 162 patients who underwent TAE with SH and 266 patients who underwent EH. The pooled intraoperative blood loss was less in the TAE with SH cohort, as compared to the EH cohort without significant difference (p = .20). The pooled blood transfer rate (p&lt;.00001), blood transfer volume (p = .002), and 30-day patient death (p = .04) were all markedly reduced in the TAE with SH cohort versus the EH cohort. No significant differences in surgery duration (p = .27), hospital stay period (p = .81), complication rate (p = 0.92), disease-free survival (DFS) (p = .79), and overall survival (OS) (p = 0.28) were found between the two groups. Compared with EH for ruptured HCC, TAE with SH could effectively decrease intraoperative blood loss and 30-day mortality. However, the long-term DFS and OS might not be beneficial to preoperative TAE.</description><identifier>ISSN: 1364-5706</identifier><identifier>EISSN: 1365-2931</identifier><identifier>DOI: 10.1080/13645706.2021.1986724</identifier><identifier>PMID: 34634985</identifier><language>eng</language><publisher>England: Taylor &amp; Francis</publisher><subject>Hepatectomy ; hepatocellular carcinoma ; rupture ; transarterial embolization</subject><ispartof>Minimally invasive therapy and allied technologies, 2022-06, Vol.31 (5), p.676-683</ispartof><rights>2021 Society of Medical Innovation and Technology 2021</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c366t-f83db7b58ff493272f91d1c2b5477f0f52b6f1a037fb7f5002ade95b16077a9d3</citedby><cites>FETCH-LOGICAL-c366t-f83db7b58ff493272f91d1c2b5477f0f52b6f1a037fb7f5002ade95b16077a9d3</cites><orcidid>0000-0002-6772-6557</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34634985$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zhang, Feng-Qin</creatorcontrib><creatorcontrib>Li, Lin</creatorcontrib><creatorcontrib>Huang, Ping-Chao</creatorcontrib><creatorcontrib>Fu, Yu-Fei</creatorcontrib><creatorcontrib>Xu, Qing-Song</creatorcontrib><title>Transarterial embolization with hepatectomy for ruptured hepatocellular carcinoma: a meta-analysis</title><title>Minimally invasive therapy and allied technologies</title><addtitle>Minim Invasive Ther Allied Technol</addtitle><description>To compare the clinical effectiveness between transarterial embolization (TAE) with staged hepatectomy (SH) and emergency hepatectomy (EH) for ruptured hepatocellular carcinoma (HCC). Pubmed, Embase, and Cochrane Library databases were screened for eligible publications from the inception of the databases till February 2021. This meta-analysis included seven studies comprising 162 patients who underwent TAE with SH and 266 patients who underwent EH. The pooled intraoperative blood loss was less in the TAE with SH cohort, as compared to the EH cohort without significant difference (p = .20). The pooled blood transfer rate (p&lt;.00001), blood transfer volume (p = .002), and 30-day patient death (p = .04) were all markedly reduced in the TAE with SH cohort versus the EH cohort. No significant differences in surgery duration (p = .27), hospital stay period (p = .81), complication rate (p = 0.92), disease-free survival (DFS) (p = .79), and overall survival (OS) (p = 0.28) were found between the two groups. Compared with EH for ruptured HCC, TAE with SH could effectively decrease intraoperative blood loss and 30-day mortality. However, the long-term DFS and OS might not be beneficial to preoperative TAE.</description><subject>Hepatectomy</subject><subject>hepatocellular carcinoma</subject><subject>rupture</subject><subject>transarterial embolization</subject><issn>1364-5706</issn><issn>1365-2931</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9kEtPwzAMgCME4jH4CaAeuXTk0TQNJxDiJSFxGefIaRMRlDYjSYXGr6djG0dOjuzPsf0hdE7wnOAGXxFWV1zgek4xJXMim1rQag8dT3leUsnI_u-7KtfQETpJ6QNPJGfNITpiVc0q2fBjpBcRhgQxm-jAF6bXwbtvyC4MxZfL78W7WUI2bQ79qrAhFnFc5jGablMIrfF-9BCLFmLrhtDDdQFFbzKUMIBfJZdO0YEFn8zZNs7Q28P94u6pfHl9fL67fSlbVte5tA3rtNC8sbaSjApqJelISzWvhLDYcqprSwAzYbWwfDoGOiO5JjUWAmTHZuhy8-8yhs_RpKx6l9b7wWDCmBTlDaGNrCSZUL5B2xhSisaqZXQ9xJUiWK31qp1etdartnqnvovtiFH3pvvr2vmcgJsN4IZJVg9fIfpOZVj5EO1kunVJsf9n_ABAroub</recordid><startdate>202206</startdate><enddate>202206</enddate><creator>Zhang, Feng-Qin</creator><creator>Li, Lin</creator><creator>Huang, Ping-Chao</creator><creator>Fu, Yu-Fei</creator><creator>Xu, Qing-Song</creator><general>Taylor &amp; Francis</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-6772-6557</orcidid></search><sort><creationdate>202206</creationdate><title>Transarterial embolization with hepatectomy for ruptured hepatocellular carcinoma: a meta-analysis</title><author>Zhang, Feng-Qin ; Li, Lin ; Huang, Ping-Chao ; Fu, Yu-Fei ; Xu, Qing-Song</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c366t-f83db7b58ff493272f91d1c2b5477f0f52b6f1a037fb7f5002ade95b16077a9d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Hepatectomy</topic><topic>hepatocellular carcinoma</topic><topic>rupture</topic><topic>transarterial embolization</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zhang, Feng-Qin</creatorcontrib><creatorcontrib>Li, Lin</creatorcontrib><creatorcontrib>Huang, Ping-Chao</creatorcontrib><creatorcontrib>Fu, Yu-Fei</creatorcontrib><creatorcontrib>Xu, Qing-Song</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Minimally invasive therapy and allied technologies</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zhang, Feng-Qin</au><au>Li, Lin</au><au>Huang, Ping-Chao</au><au>Fu, Yu-Fei</au><au>Xu, Qing-Song</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Transarterial embolization with hepatectomy for ruptured hepatocellular carcinoma: a meta-analysis</atitle><jtitle>Minimally invasive therapy and allied technologies</jtitle><addtitle>Minim Invasive Ther Allied Technol</addtitle><date>2022-06</date><risdate>2022</risdate><volume>31</volume><issue>5</issue><spage>676</spage><epage>683</epage><pages>676-683</pages><issn>1364-5706</issn><eissn>1365-2931</eissn><abstract>To compare the clinical effectiveness between transarterial embolization (TAE) with staged hepatectomy (SH) and emergency hepatectomy (EH) for ruptured hepatocellular carcinoma (HCC). Pubmed, Embase, and Cochrane Library databases were screened for eligible publications from the inception of the databases till February 2021. This meta-analysis included seven studies comprising 162 patients who underwent TAE with SH and 266 patients who underwent EH. The pooled intraoperative blood loss was less in the TAE with SH cohort, as compared to the EH cohort without significant difference (p = .20). The pooled blood transfer rate (p&lt;.00001), blood transfer volume (p = .002), and 30-day patient death (p = .04) were all markedly reduced in the TAE with SH cohort versus the EH cohort. No significant differences in surgery duration (p = .27), hospital stay period (p = .81), complication rate (p = 0.92), disease-free survival (DFS) (p = .79), and overall survival (OS) (p = 0.28) were found between the two groups. Compared with EH for ruptured HCC, TAE with SH could effectively decrease intraoperative blood loss and 30-day mortality. However, the long-term DFS and OS might not be beneficial to preoperative TAE.</abstract><cop>England</cop><pub>Taylor &amp; Francis</pub><pmid>34634985</pmid><doi>10.1080/13645706.2021.1986724</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0002-6772-6557</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1364-5706
ispartof Minimally invasive therapy and allied technologies, 2022-06, Vol.31 (5), p.676-683
issn 1364-5706
1365-2931
language eng
recordid cdi_pubmed_primary_34634985
source Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list)
subjects Hepatectomy
hepatocellular carcinoma
rupture
transarterial embolization
title Transarterial embolization with hepatectomy for ruptured hepatocellular carcinoma: a meta-analysis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T07%3A50%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Transarterial%20embolization%20with%20hepatectomy%20for%20ruptured%20hepatocellular%20carcinoma:%20a%20meta-analysis&rft.jtitle=Minimally%20invasive%20therapy%20and%20allied%20technologies&rft.au=Zhang,%20Feng-Qin&rft.date=2022-06&rft.volume=31&rft.issue=5&rft.spage=676&rft.epage=683&rft.pages=676-683&rft.issn=1364-5706&rft.eissn=1365-2931&rft_id=info:doi/10.1080/13645706.2021.1986724&rft_dat=%3Cproquest_pubme%3E2581289491%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c366t-f83db7b58ff493272f91d1c2b5477f0f52b6f1a037fb7f5002ade95b16077a9d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2581289491&rft_id=info:pmid/34634985&rfr_iscdi=true